OptumRx PBM of Maryland, Inc. Sustainability Profile
OptumRx PBM of Maryland, Inc., a prominent player in the pharmacy benefit management (PBM) industry, is headquartered in the United States. Established in 2011, the company has rapidly expanded its operational footprint across major regions, providing innovative solutions to optimise medication management and enhance patient care. Specialising in a range of services, including formulary management, medication adherence programmes, and cost containment strategies, OptumRx distinguishes itself through its data-driven approach and commitment to improving health outcomes. The company has achieved significant milestones, positioning itself as a leader in the PBM sector, recognised for its ability to streamline pharmacy services and reduce overall healthcare costs. With a focus on delivering value to clients and members alike, OptumRx PBM of Maryland, Inc. continues to set benchmarks in the industry, making it a trusted partner for healthcare organisations seeking effective pharmacy solutions.
DitchCarbon Score
How does OptumRx PBM of Maryland, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Insurance Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
OptumRx PBM of Maryland, Inc.'s score of 72 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
OptumRx PBM of Maryland, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. As a current subsidiary of UnitedHealth Group Incorporated, any climate commitments or emissions data would be cascaded from this parent organisation. While there are no documented reduction targets or specific emissions figures for OptumRx, it is important to note that the climate initiatives and targets set by UnitedHealth Group may influence OptumRx's sustainability efforts. UnitedHealth Group has been actively involved in various climate initiatives, including the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), which aim to reduce greenhouse gas emissions across their operations. As of now, OptumRx has not publicly committed to specific reduction targets or initiatives, but it is positioned within a corporate family that prioritises climate action and sustainability. The absence of direct emissions data highlights the need for further transparency and commitment to environmental accountability within the organisation.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 15,838,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 161,303,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 146,373,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
How Carbon Intensive is OptumRx PBM of Maryland, Inc.'s Industry?
How Carbon Intensive is OptumRx PBM of Maryland, Inc.'s Location?
OptumRx PBM of Maryland, Inc.'s Scope 3 Categories Breakdown
OptumRx PBM of Maryland, Inc.'s Scope 3 emissions, which decreased by 3% last year and increased significantly since 2016, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Investments" being the largest emissions source at 51% of Scope 3 emissions.
Top Scope 3 Categories
OptumRx PBM of Maryland, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
OptumRx PBM of Maryland, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
